Stable plasma magnesium status in essential hypertensive patients treated with angiotensin II antagonists

Magnesium - Bulletin

Volumn 22, Issue 4, 2000, Pages 92-94

  Kisters, K ^a   Wessels, F ^a   Tokmak, F ^a   Hausberg, M ^b   Barenbrock, M ^c   Kosch, M ^b  

^a ST ANNA HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Dialysezentrum Hamm ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23044522907     PISSN: 0172908X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J. Hypertens. 17 (1999) 151-183.
2. Kisters, K.: Therapie der essentiellen Hypertonie. Nieren- und Hochdruckkrkh. 28 (1999) 229-233.
3. Altura, B. M.; Altura, B. T.; Carella, A.: Magnesium deficiency - induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation. Science 221 (1983) 376-378.
4. ++ concentrations in pre-eclampsia. J. Hypertens. 8 (1990) 303-306.
5. ++ (Correspondence letter). J. Hypertens. 16 (1998) 1561-1562.
6. ++ concentrations in a subgroup of hypertensives. Am. J. Hypertens. 11 (1998) 1390-1393.
7. Kosch, M.; Hausberg, M.; Westermann, G.; Köneke, J.; Matzkies, F.; Rahn, K. H.; Kisters, K.: Increased membranous calcium and decreased magnesium concentrations in the pathogenesis of primary hypertension: a possible calcium magnesium antagonism (2001) (in press), Am. J. Hypertens.
8. Seelig, M. S.: Magnesium deficiency in the pathogenesis of disease. Plenum Press, New York 1980.
9. Kisters, K.; Krefting, E. R.; Hausberg, M.; Kohnert, K. D.; Honig, A.; Bettin, D.: Importance of decreased intracellular phosphate and magnesium concentrations and reduced ATPase activities in spontaneously hypertensive rats. Magnes. Res. 13, 3 (2000) 183-188.
10. + exchange in vascular smooth muscle cells from SHR. Clin. Sci. 95 (1998) 583-587.
11. ++ in the pathogenesis of primary hypertension. J. Hypertens. (in press) (2000).
12. Kisters, K.: Kombinationstherapie mit ACE-Hemmern und Angiotensin-Rezeptor-Antagonisten. Internist 40 (1999) 678-679.
13. Goodfriend, T. L.; Elliott, M. E.; Catt, K. J.: Angiotensin receptors and their antagonists. N. Engl. J. Med. 334 (1996) 1649-1654.
14. Hollenberg, N. K.: ACE inhibitors, AT1 receptor blockers, and the kidney. NDT 12 (1997) 381-383.
15. Ferrario, C. M.; Gildenberg, P. C.; Mc Cubbin, J. W.: Cardio- vascular effects of angiotensin mediated by the central nervous system. Circ. Res. 30 (1997) 257-262.
16. Illyes, G.; Talarico, P. J.; Simon, G.: Different structural vascular changes in angiotensin II-treated and cold-stressed rats. Am. J. Hypertens. 13 (2000) 802-809.
17. Ryzen, E.; Greenspoon, J. S.; Diesfeld, P.; Rude, R. K.: Blood mononuclear cell magnesium in normal pregnancy and pre-eclampsia. J. Am. Coll. Nutr. 6 (1987) 121-124.
18. White, R. E.; Hartzell, H. C.: Effects of intracellular free magnesium on calcium current in isolated cardiac myocytes. Science 239 (1988) 778-780.
19. Kosch, M.; Hausberg, M.; Vormbrock, K.; Kisters, K.; Gabriels, G.; Rahn, K. H.; Barenbrock, M.: Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc. Res. 47 (2000) 813-818.
20. Kisters, K.; Spieker, C.; Zidek, W.: Plasma and membrane calcium and magnesium content in hypertensive patients and controls. Trace Elem. Electolyt. 4 (1995) 169-172.
21. ++ in the arterial wall. J. Physiol. (London) 218 (1971) 353-368.